1. Survival in Resected Stage I Lung Cancer With Residual Tumor at the Bronchial Resection Margin 
Repke J Snijder, Aart Brutel de la Rivière, Hans J.J Elbers, Jules M.M van den Bosch 
The Annals of Thoracic Surgery 
Volume 65, Issue 1, Pages (January 1998)
DOI: /S (97)

2. Fig. 1
Cumulative survival in patients in complete resection group (solid line), those with carcinoma in situ (dotted line), and those with invasive tumor (mucosal or peribronchial residual disease) (dashed line). Complete resection versus carcinoma in situ, p = 0.74; carcinoma in situ versus invasive tumor, p = 0.16; complete resection versus invasive tumor, p = 0.03.
The Annals of Thoracic Surgery  , DOI: ( /S (97) )

3. Fig. 2
Recurrence data broken down according to pattern of residual disease. (CIS = carcinoma in situ; CR = complete resection; MRD = mucosal residual disease; PRD = peribronchial residual disease; white bars = local recurrent disease; hatched bars = distant recurrent disease; black bars = local + distant recurrent disease.)
The Annals of Thoracic Surgery  , DOI: ( /S (97) )